Retreatment with rituximab based on a treatment-to-target approach provides better disease control than treatment as needed in patients with rheumatoid arthritis: a retrospective pooled analysis

Objective. To assess the efficacy and safety profiles of two different rituximab retreatment regimens in patients with RA. Methods. Four hundred and ninety-three RA patients with an inadequate response to MTX recruited into rituximab Phase II/III studies received further courses of open-label rituxi...

Descripción completa

Detalles Bibliográficos
Autores principales: Emery, Paul, Mease, Philip J., Rubbert-Roth, Andrea, Curtis, Jeffrey R., Müller-Ladner, Ulf, Gaylis, Norman B., Williams, Sarah, Reynard, Mark, Tyrrell, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222846/
https://www.ncbi.nlm.nih.gov/pubmed/21926153
http://dx.doi.org/10.1093/rheumatology/ker253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222846/
https://www.ncbi.nlm.nih.gov/pubmed/21926153
http://dx.doi.org/10.1093/rheumatology/ker253

Ejemplares similares